Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas

Clinical trial NCT03808558 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03808558
Sponsor: David E Gerber
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

KRAS Gene Mutation

Start date: 2019-09-11
Primary completion: 2025-04-03
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.